Degarelix: a novel gonadotropin-releasing hormone blocker for the treatment of prostate cancer

By Anderson John  

Future Oncology, Vol. 5, Iss. 4, 2009-05 ,pp. : 433-443

Future Medicine

Access to resources Recommend Favorite

Thrombospondins, metallo proteases and thrombospondin receptors messenger RNA and protein expression in different tumour sublines of the Dunning prostate cancer model

By Vallbo Christina   Damber Jan-Erik  

Acta Oncologica, Vol. 44, Iss. 3, 2005-05 ,pp. : 293-298

Informa Healthcare

Access to resources Recommend Favorite

Abarelix for injectable suspension: first-in-class gonadotropin-releasing hormone antagonist for prostate cancer

By Debruyne Frans   Bhat Gajanan   Garnick Marc B  

Future Oncology, Vol. 2, Iss. 6, 2006-12 ,pp. : 677-696

Future Medicine

Access to resources Recommend Favorite

Single nucleotide polymorphisms in the regulatory region of gonadotropin-releasing hormone receptor gene and breast cancer susceptibility

By              

Oncology Reports, Vol. 28, Iss. 3, 2012-01 ,pp. : 1091-1095

Spandidos Publications

Access to resources Recommend Favorite

Letrozole combined with gonadotropin-releasing hormone analog for metastatic male breast cancer

By Lauro Luigi   Vici Patrizia   Medico Pietro   Laudadio Lucio   Tomao Silverio   Giannarelli Diana   Pizzuti Laura   Sergi Domenico   Barba Maddalena   Maugeri-Saccà Marcello  

Breast Cancer Research and Treatment, Vol. 141, Iss. 1, 2013-08 ,pp. : 119-123

Springer Publishing Company

Access to resources Recommend Favorite